Retreatment tuberculosis cases: Factors associated with drug resistance and adverse outcomes

Chest

Volumn 111, Issue 5, 1997, Pages 1162-1167

  Kritski, Afranio L ^a   Rodrigues De Jesus, Luis Sergio ^a   Andrade, Monica K ^d   Werneck Barroso, Eduardo ^a   Vieira, Maria Armanda Monteiro S ^a   Haffner, Alice ^b   Riley, Lee W ^b,c  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NONE

Author keywords

DOT; multi drug resistant TB; TB retreatment; tuberculosis

Indexed keywords

ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; AGED; ARTICLE; BRAZIL; DRUG SENSITIVITY; FEMALE; HUMAN; LOBECTOMY; LUNG RESECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RELAPSE; RISK FACTOR; SPUTUM SMEAR; THORAX RADIOGRAPHY; TREATMENT FAILURE;

EID: 0030942617     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.111.5.1162     Document Type: Article

References (16)

1. Costello HD, Caras GJ, Snider DE, Jr. Drug resistance among previously treated tuberculosis patients: a brief report. Am Rev Respir Dis 1980; 121:313-16
2. US Public Health Service Cooperative Investigation. Prevalence of drug resistance in previously untreated patients. Am Rev Respir Dis 1964; 89:327-36
3. Shennan DH, Resistance of tubercle bacilli to isoniazid, PAS, and streptomycin, related to history of previous treatment. Tubercle 1964; 45:1-6
4. Riley LW, Arathoon E, Loverde VD. The epidemiologic patterns of drug-resistant Mycobacterium-tuberculosis infections: a community-based study. Am Rev Respir Dis 1989; 139:1282-85
5. Departamento de Doenças Transmissíveis. Secretaria de Estado Saiúde e Higiene do Estado do Rio de Janeiro. Resultados da avaliaçao dos programas de controle de tuberculose no Estado do Rio de Janeiro, 1986
6. Canetti G, Grosset JH. Techniques et indications des exames bacteriologiques en tuberculose. Editions de la Tourelle, St. Mande, France; 1968
7. Smith PG, Morrow RH, eds. Methods for field trials of interventions against tropical diseases. Oxford: Oxford University Press, 1991; 289-93
8. Masur J, Monteiro MG. Validation of the 'CAGE' alcoholism screening test in a Brazilian psychiatric inpatient hospital setting. Braz J Med 1983; 16:215-18
9. Poppe de Figueiredo F. Treatment for patients with pulmonary tuberculosis classified according to the history of previous chemotherapy and without reference to pre-treatment drug sensitivity, Tubercle 1969; 50:335-43
10. Goble M, Iseman MD, Madsen LA, et al. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med 1993; 328:527-732
11. World Health Organization. Guidelines for tuberculosis treatment in adults and children in National Tuberculosis Programmes. Geneva: WHO/TUB, 1991; 161
12. Manalo F, Tan F, Sbarbaro JA, et al. Community-based short-course treatment of pulmonary tuberculosis in a developing nation. Am Rev Respir Dis 1990; 142:1301-05
13. Iseman MD. Treatment of multidrug-resistant tuberculosis. N Engl J Med 1993; 329:784-91
14. Ben-Dov I, Mason GR. Drug-resistant tuberculosis in a southern California hospital: trends from 1969 to 1984. Am Rev Respir Dis 1987; 135:1307-10
15. Frieden TR, Fujiwara PI, Washko RM, et al. Tuberculosis in New York City - turning the tide. N Engl J Med 1995; 333:229-33
16. TB Program, World Health Organization. TB, a global emergency: WHO report on the TB epidemic. Geneva: WHO/TB, 1994; 94-177